Log in

NASDAQ:AKTSAkoustis Technologies Stock Price, Forecast & News

$8.05
+0.06 (+0.75 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.82
Now: $8.05
$8.07
50-Day Range
$7.63
MA: $8.16
$8.88
52-Week Range
$3.76
Now: $8.05
$9.40
Volume480,156 shs
Average Volume462,502 shs
Market Capitalization$293.58 million
P/E RatioN/A
Dividend YieldN/A
Beta1.68
Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., develops, designs, manufactures, and sells radio frequency (RF) filter products for the mobile wireless device industries in the United States. The company operates through two segments, Foundry Fabrication Services and RF Filters. The Foundry Fabrication Services segment provides engineering review services; and smart systems technology and commercialization center foundry, as well as manufacturing and microelectromechanical systems foundry services. The RF Filters segment consists of amplifier and filter products. It offers RF filters for mobile wireless devices, such as smartphones and tablets, cellular infrastructure equipment, and Wi-Fi premise equipment. The company was founded in 2014 and is headquartered in Huntersville, North Carolina.
Read More
Akoustis Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars


Industry, Sector and Symbol

Industry Telephone & telegraph apparatus
Sub-IndustryN/A
Current SymbolNASDAQ:AKTS
CUSIPN/A
Phone704-997-5735

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.44 million
Book Value$0.87 per share

Profitability

Net Income$-29,250,000.00
Net Margins-1,595.99%

Miscellaneous

Employees69
Market Cap$293.58 million
Next Earnings DateN/A
OptionableNot Optionable
$8.05
+0.06 (+0.75 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AKTS News and Ratings via Email

Sign-up to receive the latest news and ratings for AKTS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Akoustis Technologies (NASDAQ:AKTS) Frequently Asked Questions

How has Akoustis Technologies' stock been impacted by COVID-19 (Coronavirus)?

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AKTS stock has increased by 51.6% and is now trading at $8.05.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Akoustis Technologies?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Akoustis Technologies
.

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies Inc (NASDAQ:AKTS) issued its earnings results on Monday, May, 4th. The technology company reported ($0.21) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.20) by $0.01. The technology company had revenue of $0.36 million for the quarter, compared to analysts' expectations of $0.51 million. Akoustis Technologies had a negative return on equity of 87.59% and a negative net margin of 1,595.99%.
View Akoustis Technologies' earnings history
.

What price target have analysts set for AKTS?

3 Wall Street analysts have issued 12-month price targets for Akoustis Technologies' shares. Their forecasts range from $7.00 to $11.00. On average, they anticipate Akoustis Technologies' share price to reach $9.33 in the next twelve months. This suggests a possible upside of 15.9% from the stock's current price.
View analysts' price targets for Akoustis Technologies
.

Has Akoustis Technologies been receiving favorable news coverage?

News headlines about AKTS stock have been trending somewhat negative this week, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Akoustis Technologies earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the technology company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the near term.
View the latest news about Akoustis Technologies
.

Who are some of Akoustis Technologies' key competitors?

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include NVIDIA (NVDA), Inseego (INSG), Alibaba Group (BABA), Editas Medicine (EDIT), Crispr Therapeutics (CRSP), Square (SQ), InVitae (NVTA), Marvell Technology Group (MRVL), Advanced Micro Devices (AMD) and QUALCOMM (QCOM).

Who are Akoustis Technologies' key executives?

Akoustis Technologies' management team includes the following people:
  • Mr. Jeffrey B. Shealy, Founder,Pres, CEO & Director (Age 50)
  • Mr. David M. Aichele, VP of Bus. Devel. (Age 53)
  • Mr. Kenneth Boller, Interim Chief Financial Officer
  • Mr. Thomas Andrew Sepenzis, Director of Investor Relations (Age 47)
  • Mr. Drew Wright, Gen. Counsel & Corp. Sec.

What is Akoustis Technologies' stock symbol?

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Who are Akoustis Technologies' major shareholders?

Akoustis Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include UBS Group AG (1.08%), Taylor Frigon Capital Management LLC (1.05%), Handelsinvest Investeringsforvaltning (0.75%), Mission Wealth Management LP (0.69%), Roubaix Capital LLC (0.26%) and SG Americas Securities LLC (0.25%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, John T Kurtzweil, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends for Akoustis Technologies
.

Which institutional investors are selling Akoustis Technologies stock?

AKTS stock was sold by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, and Mission Wealth Management LP. Company insiders that have sold Akoustis Technologies company stock in the last year include David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, Rohan Houlden, and Steven Denbaars.
View insider buying and selling activity for Akoustis Technologies
.

Which institutional investors are buying Akoustis Technologies stock?

AKTS stock was bought by a variety of institutional investors in the last quarter, including Roubaix Capital LLC, SG Americas Securities LLC, UBS Group AG, Handelsinvest Investeringsforvaltning, SeaCrest Wealth Management LLC, Taylor Frigon Capital Management LLC, Chartwell Investment Partners LLC, and Parsec Financial Management Inc..
View insider buying and selling activity for Akoustis Technologies
.

How do I buy shares of Akoustis Technologies?

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Akoustis Technologies' stock price today?

One share of AKTS stock can currently be purchased for approximately $8.05.

How big of a company is Akoustis Technologies?

Akoustis Technologies has a market capitalization of $293.58 million and generates $1.44 million in revenue each year. Akoustis Technologies employs 69 workers across the globe.

What is Akoustis Technologies' official website?

The official website for Akoustis Technologies is www.akoustis.com.

How can I contact Akoustis Technologies?

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at 704-997-5735 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.